182 related articles for article (PubMed ID: 30045664)
21. Brain-derived neurotrophic factor-dependent cdk1 inhibition prevents G2/M progression in differentiating tetraploid neurons.
Ovejero-Benito MC; Frade JM
PLoS One; 2013; 8(5):e64890. PubMed ID: 23741412
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
Li QQ; Hsu I; Sanford T; Railkar R; Balaji N; Sourbier C; Vocke C; Balaji KC; Agarwal PK
Cell Mol Life Sci; 2018 Mar; 75(5):939-963. PubMed ID: 29071385
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
[TBL] [Abstract][Full Text] [Related]
24. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
25. Chemical genetic analyses of quantitative changes in Cdk1 activity during the human cell cycle.
Gravells P; Tomita K; Booth A; Poznansky J; Porter AC
Hum Mol Genet; 2013 Jul; 22(14):2842-51. PubMed ID: 23525902
[TBL] [Abstract][Full Text] [Related]
26. SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition.
Kim JA; Lee J; Margolis RL; Fotedar R
Oncogene; 2010 Mar; 29(11):1702-16. PubMed ID: 20062077
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
Kuger S; Flentje M; Djuzenova CS
Radiat Oncol; 2015 Oct; 10():214. PubMed ID: 26498922
[TBL] [Abstract][Full Text] [Related]
28. Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia.
Djuzenova CS; Blassl C; Roloff K; Kuger S; Katzer A; Niewidok N; Günther N; Polat B; Sukhorukov VL; Flentje M
Cancer Biol Ther; 2012 Apr; 13(6):425-34. PubMed ID: 22286776
[TBL] [Abstract][Full Text] [Related]
29. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks.
Sert V; Cans C; Tasca C; Bret-Bennis L; Oswald E; Ducommun B; De Rycke J
Oncogene; 1999 Nov; 18(46):6296-304. PubMed ID: 10597228
[TBL] [Abstract][Full Text] [Related]
30. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.
Barboule N; Lafon C; Chadebech P; Vidal S; Valette A
FEBS Lett; 1999 Feb; 444(1):32-7. PubMed ID: 10037143
[TBL] [Abstract][Full Text] [Related]
31. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
Wang Y; Li J; Booher RN; Kraker A; Lawrence T; Leopold WR; Sun Y
Cancer Res; 2001 Nov; 61(22):8211-7. PubMed ID: 11719452
[TBL] [Abstract][Full Text] [Related]
33. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
[TBL] [Abstract][Full Text] [Related]
34. Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.
Wang J; Chang L; Lai X; Li X; Wang Z; Huang Z; Huang J; Zhang G
Cell Cycle; 2018; 17(6):671-680. PubMed ID: 29285984
[TBL] [Abstract][Full Text] [Related]
35. CDK1 hyperphosphorylation maintenance drives the time-course of G2-M cell cycle arrest after short treatment with NAMI-A in Kb cells.
Bergamo A; Delfino R; Casarsa C; Sava G
Anticancer Agents Med Chem; 2012 Oct; 12(8):949-58. PubMed ID: 22263785
[TBL] [Abstract][Full Text] [Related]
36. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
[TBL] [Abstract][Full Text] [Related]
38. Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited.
Potapova TA; Sivakumar S; Flynn JN; Li R; Gorbsky GJ
Mol Biol Cell; 2011 Apr; 22(8):1191-206. PubMed ID: 21325631
[TBL] [Abstract][Full Text] [Related]
39. G2 checkpoint kinase inhibitors exert their radiosensitizing effects prior to the G2/M transition.
Sturgeon CM; Roberge M
Cell Cycle; 2007 Mar; 6(5):572-5. PubMed ID: 17351346
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.
Dukaew N; Konishi T; Chairatvit K; Autsavapromporn N; Soonthornchareonnon N; Wongnoppavich A
Oncol Res; 2020 Mar; 28(2):161-175. PubMed ID: 31727206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
